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Abstract
Background: Non-negative matrix factorization (NMF) has been shown to be a powerful tool for clustering gene
expression data, which are widely used to classify cancers. NMF aims to ﬁnd two non-negative matrices whose
product closely approximates the original matrix. Traditional NMF methods minimize either the l2 norm or the
Kullback-Leibler distance between the product of the two matrices and the original matrix. Correntropy was recently
shown to be an eﬀective similarity measurement due to its stability to outliers or noise.
Results: We propose a maximum correntropy criterion (MCC)-based NMF method (NMF-MCC) for gene expression
data-based cancer clustering. Instead of minimizing the l2 norm or the Kullback-Leibler distance, NMF-MCC maximizes
the correntropy between the product of the two matrices and the original matrix. The optimization problem can be
solved by an expectation conditional maximization algorithm.
Conclusions: Extensive experiments on six cancer benchmark sets demonstrate that the proposed method is
signiﬁcantly more accurate than the state-of-the-art methods in cancer clustering.
Background
Because cancer has been a leading cause of death in the
world for several decades, the classiﬁcation of cancers is
becoming more and more important to cancer treatment
and prognosis [1,2]. With advances in DNA microarray
technology, it is now possible to monitor the expression
levels of a large number of genes at the same time. There
have been a variety of studies on analyzing DNA microar-
ray data for cancer class discovery [3-5]. Suchmethods are
demonstrated to outperform the traditional, morpholog-
ical appearance-based cancer classiﬁcation methods. In
such studies, diﬀerent cancer classes are discriminated by
their corresponding gene expression proﬁles [1].
Several clustering algorithms have been used to identify
groups of similar expressed genes. Non-negative matrix
factorization (NMF) was recently introduced to analyze
gene expression data and this method demonstrated supe-
rior performance in terms of both accuracy and stability
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[6-8]. Gao and Church [3] reported an eﬀective unsuper-
vised method for cancer clustering with gene expression
proﬁles via sparse NMF (SNMF). Carmona et al. [9] pre-
sented a methodology that was able to cluster closely
related genes and conditions in sub-portions of the data
based on non-smooth non-negative matrix factorization
(nsNMF), which was able to identify localized patterns in
large datasets. Zheng et al. [5,7] applied penalized matrix
decomposition (PMD) to extract meta-samples from gene
expression data, which could captured the inherent struc-
tures of samples that belonged to the same class.
NMF approximates a given gene data matrix, X, as a
product of two low-rank nonnegative matrices, H and W,
as X ≈ HW . This is usually formulated as an optimiza-
tion problem, where the objective function is to minimize
either the l2 norm or the Kullback-Leibler (KL) distance
[10] betweenX andHW .Most of the improvedNMF algo-
rithms are also based on the minimization of these two
distances while adding the sparseness term [3], the graph
regularization term [11], etc. Sandler and Lindenbaum
[12] argued that measuring the dissimilarity ofW andHW
by either the l2 norm or the KL distance, even with addi-
tional bias terms, was inappropriate in computer vision
applications due to the nature of errors in images. Sandler
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and Lindenbaum [12] proposed a novel NMF with earth
mover’s distance (EMD) metric by minimizing the EMD
error betweenX andHW . The proposedNMF-EMD algo-
rithm demonstrated signiﬁcantly improved performance
in two challenging computer vision tasks, i.e., texture clas-
siﬁcation and face recognition. Liu et al. [4] tested a family
of NMF algorithms using α-divergence with diﬀerent α
values as dissimilarities between X and HW for clustering
cancer gene expression data.
It is widely acknowledged that DNAmicroarry data con-
tain many types of noise, especially experimental noise.
Recently, correntropy was shown to be an eﬀective sim-
ilarity measurement in information theory due to its
stability to outliers or noise [13]. However, it has not
been used in the analysis of microarray data. In this
paper, we propose a novel form of NMF that maximizes
the correntropy. We introduce a new NMF algorithm
with a maximum correntropy criterion (MCC) [13] for
the gene expression data-based cancer clustering prob-
lem. We call it NMF-MCC. The goal of NMF-MCC is
to ﬁnd a meta-sample matrix, H, and a coding matrix,
W, such that the gene expression data matrix, X, is
as correlative to the product of H and W as possible
under MCC.
Relatedworks
He et al. [13] recently developed a face recognition algo-
rithm, correntropy-based sparse representation (CESR),
based on MCC. CESR tries to ﬁnd a group of sparse
combination coeﬃcients to maximize the correntropy
between the facial image vector and the linear combina-
tion of faces in the database. He et al. [13] demonstrated
that CESR was much more eﬀective in dealing with the
occlusion and corruption problems of face recognition
than the state-of-the-art methods. However, CESR learns
only the combination coeﬃcients while the basis faces
(the faces in the database) are ﬁxed. Comparing to CESR,
NMF-MCC can learn both the combination coeﬃcients
and the basis vectors jointly, which allows the algorithm
to obtain more basis vectors for better representation of
the data points. Zafeiriou and Petrou [14] addressed the
problem of NMF with kernel functions instead of inner
products and proposed the projected gradient kernel
nonnegative matrix factorization (PGK-NMF) algorithm.
Both NMF-MCC and PGK-NMF employ kernel functions
to map the linear data space to a non-linear space. How-
ever, as we show later, NMF-MCC computes diﬀerent
kernels for diﬀerent features, while PGK-NMF computes
a single kernel for the whole feature vector. Thus, NMF-
MCC allows the algorithm to assign diﬀerent weights to
diﬀerent features and emphasizes the discriminant fea-
tures with high weights, thus achieving feature selection.
In contrast, like most kernel based methods, PGK-NMF
simply replaces the inner product by the kernel-function
and treats the features equally, thus there is no feature
selection function.
Methods
In this section, we ﬁrst brieﬂy introduce the traditional
NMF method. We then propose our novel NMF-MCC
algorithm by maximizing the correntropy in NMF. We
further propose a expectation conditional maximization-
based approach to solve the optimization problem.
Nonnegativematrix factorization
NMF is a matrix factorization algorithm that focuses on
the analysis of data matrices whose elements are nonneg-
ative. Consider a gene expression dataset that consists of
D genes in N samples. We denote it by a matrix X =
[ x1, · · · , xN ]∈ RD×N of size D × N , and each column of
X is a sample vector containing D genes. NMF aims to
ﬁnd two non-negative matrices, H =[ hdk]∈ RD×K and
W =[wkn]∈ RK×N , whose product closely approximates
the original matrix X:
X ≈ HW . (1)
Matrix H is of size D × K , with each of the K columns
deﬁning a meta-sample and each entry, hdk , in H repre-
senting the expression level of gene d over meta-sample
k. Matrix W is of size K × N , with each of the n columns
representing the meta-sample expression pattern of the
corresponding sample, and each entry, wkn, representing
the coeﬃcient of meta-sample k over sample n. Figure 1
shows an example of the factorization of a gene expres-
sion matrix X with D = 2308 genes and N = 83 samples
as the product of the meta-sample matrix H with K = 4
meta-samples and the coding matrixW.
The factorization is quantiﬁed by an objective function
that minimizes some distance measure, such as:
• l2 norm distance: One simple measure is the square
of the l2 norm distance (also known as the Frobenius
norm or the Euclidean distance) between two













• Kullback - Leibler (KL) divergence: The second
one is the divergence between two matrices [10],
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Figure 1 The l2 norm distance-based non-negative matrix factorization on the SRBCT dataset [29]. The gene expression data matrix, X, is
factorized as the product of the meta-sample matrix, H, and the coding matrix,W .
Maximum correntropy criterion for NMF
Another thing that has to be changed is that the deﬁnition
of correntropy is not subject to the kernel being Gaussian
as they seem to imply through the text, so for instance
when they deﬁne they can say E(k(x-y)) and one of the
common choices of k is the Gaussian kernel giving....
Correntropy is a nonlinear similarity measure between
two random variables, x and y [13,15,16], deﬁned as
Vσ (x, y) = E[ kσ (x − y)] , (4)
where kσ is a kernel that satisﬁes the Mercer theory and
E[ ·] is the expectation. One of the common choices of kσ
is the Gaussian kernel given as kσ (x − y) = exp(− (x−y)22σ 2 ).
In practice, the joint probability density function of
x and y is unknown and only a ﬁnite amount of data
{(xi, yi)}, i = 1, · · · , I is available. Therefore, the sample
correntropy is estimated by
V̂σ (x, y) = 1I
I∑
i=1
kσ (xi − yi), (5)
Based on Eq. (5), a general similarity measurement
between any two discrete gene expression vectors was
proposed [17]. They introduced the correntropy induced
metric (CIM) for any two gene sample vectors x =
[ x1, · · · , xD] and y =[ y1, · · · , yD], as:
CIM(x, y) =
(
kσ (0) + 1D
D∑
d=1











where ed = xd−yd is deﬁned as the error. For adaptive sys-






kσ (xd − yd),
kσ (xd − yd) = exp
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where  is a parameter to be speciﬁed later. We must
notice the diﬀerence between MCC and common kernel
criterion used in [14]. The Gaussian kernel function of
vectors x and y is deﬁned as















We can see that the kernel is applied to the entire fea-
ture vector, x, and each feature xd, d = 1 · · · ,D is treated
equally with the same kernel parameter. However, in (7),
kernel functions are applied to diﬀerent functions. This
can allow the algorithm to learn diﬀerent kernel parame-
ters as we will introduce later. In this way, we can assign
diﬀerent weights to diﬀerent features and thus implement
feature selection.
Our goal is to ﬁnd a meta-sample matrix, H, and a
coding matrix, W, such that HW is as correlative to
X as possible under MCC as described in Eq. (7). To
extend MCC from vector space RD to matrix space RD×N ,
we replace ed = (xd − yd) with the l2 norm distance
between the samples of X and Y = HW as ed =√∑N
n=1(xdn − ydn)2, where ydn is the (d, n)-th item of Y,
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and ydn = ∑Kk=1 hdkwkn. Moreover, the factorization sys-
tem parameter should be set to  = (H ,W ) under the
framework of NMF-MCC. By substituting newly deﬁned
ed and  to (7), we can formulate the problem of NMF-




s.t. H ≥ 0, W ≥ 0.






























We should notice the signiﬁcant diﬀerence betweenNMF-
MCC and CESR. As a supervised learning algorithm,
the CESR represents a test data point, xt , as a linear
combination of all the the training data points as xt ≈∑N
n=1 xnwnt = Xwt and wt =[w1t , · · · ,wNt] is the com-
bination coeﬃcient vector. CESR aims to ﬁnd the optimal
wt to maximize the correntropy between xt and Xwt . Sim-
ilarly, NMF-MCC also tries to represent a data point xn
as a linear combination of some basis vectors as xn ≈∑K
k=1 hkwkn = Xwn and wn =[w1n, · · · ,wKn] is the
combination coeﬃcient vector. Diﬀerently from CESR,
NMF-MCC aims to ﬁnd not only the optimal wn but
also the basis vectors in H to maximize the correntropy
between xn and Hwn, n = 1, · · · ,N . The internal diﬀer-
ence between NMF-MCC and CESR lies in whether to
learn basis vectors or not.
In order to solve the optimization problem, we rec-
ognize that the expectation conditional maximization
(ECM) method [19] can be applied. Based on the the-
ory of convex conjugate functions [20], we can derive the
following proposition that forms the basis to solve the
optimization problem in (9):
Proposition 1. There exists a convex conjugate function
of g(z, σ) such that









and for a fixed z, the supremum is reached at  = −g(z, σ).
By substituting Eq. (10) into (9), we have the aug-




















where superscript ϕ is the convex conjugate function ϕ of
g(z) deﬁned in Proposition 1, and ρ =[ ρ1, · · · , ρD] are
the auxiliary variables.
According to Proposition 1, for ﬁxed H and W, the
following equation holds:
F(H ,W ) = max
ρ













F̂(H ,W , ρ).
(13)
That is, maximizing F(H ,W ) is equivalent to maximizing
the augmented function F̂(H ,W , ρ).
The NMF-MCC Algorithm
The traditional NMF can be solved by the expectation-
maximization (EM) algorithm [21]. However, in the case
of MCC-based NMF, EM must be replaced by ECM
because there is more than one parameter. Figure 2 shows
the outline of ECM, which is described in more detail
below.
1. E-Step: Compute ρ given the current estimations of
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Figure 2 Outline of the ECM-based NMF-MCC algorithm.
where t means the t-th iteration. In this study, the














where θ is a parameter to control the sparseness of ρtd.
2. CM-steps: In the CM-step, given ρtd , we try to



















s.t. H ≥ 0, W ≥ 0,
(16)
where diag(·) is an operator that converts the vector
ρ to a diagonal matrix.
By introducing a dual objective function,
O(H,W ) =Trac
[
















the optimal problem in (16) can be reformulated as




s.t. H ≥ 0, W ≥ 0.
(18)
Let φdk and ψkn be the Lagrange multiplier for
constraints hdk ≥ 0 and wkn ≥ 0, respectively, and























The partial derivatives of L with respect to H and W
are
∂L






diag(−ρt)X + 2Hdiag(−ρt)HW + 
(21)
Using the Karush-Kuhn-Tucker optimal conditions,
i.e., φdkhdk = 0 and ψknwkn = 0, we get the following
equations for hdk and wkn:
− 2(diag(−ρt)XW)dkhdk




+ 2(Hdiag(−ρt)HW )knwkn = 0
(23)
These equations lead to the following updating rules
to maximize the expectation in (13).
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• The coding matrix W conditioned on the newly





We should note that if we exchange the numerator
and denominator in (24) and (25), new update
formulas will be yield. The new update rules are dual
for (24) and (25), and our experimental results show
that the dual update rules achieve similar clustering
performances as (24) and (25).
Algorithm 1 summarizes the optimization procedure.
Algorithm 1 NMF-MCC Algorithm.
Require: Input gene expression data matrix X;
Require: Initial meta-sample gene matrix H1 and coding
matrixW 1;
for t = 1, · · · ,T do
Update the auxiliary variables ρt as in (14);
Update the meta-sample matrix Ht+1 as in (24);
Update the coding matrixWt+1 as in (25);
end for
Output H = HT+1 andW = WT+1.
Proof of convergence
In this section, we will prove that the objective function in
(16) is nonincreasing under the updating rules in (24) and
(25).
Theorem 1. The objective function in (16) is nonin-
creasing under the update rules (24) and (25).
To prove the above theorem, we ﬁrst deﬁne an auxiliary
function.
Definition 1. G(w,w′) is an auxiliary function for F(w)
if the conditions
G(w,w′) ≥ F(w), G(w,w) = F(w) (26)
are satisﬁed.
The auxiliary function is quite useful because of the
following lemma:
Lemma 1. If G is an auxiliary function of F, then F is




We refer the readers to [22] for the proof of this
lemma. Now, we show that the updating rule of (25)
is exactly the update in (27) with a proper auxil-




















Considering any element, wkn, in W, we use Fkn to
denote the part of the objective function in (16) that is

























Since the updating rule is essentially based on elements,
it is suﬃcient to show that each Fkn is nonincreasing under
the update step of (25).
Table 1 Summary of the six cancer gene expression datasets used to test the NMF-MCC algorithm
Dataset name Diagnostic task Samples (N ) Genes (D) Cancer Classes (K ) Ref
Leukemia Acute myelogenous leukemia 72 5327 3 [25]
Brain Tumor 5 human brain tumor types 90 5920 5 [26]
Lung Cancer 4 lung cancer types and normal tissues 203 12600 5 [27]
9 Tumors 9 various human tumor types 60 5726 9 [28]
SRBCT Small, round blue cell tumors 83 2308 4 [29]
DLBCL Diﬀuse large B-cell lymphomas 77 5469 2 [24]
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Lemma 2. Function






is an auxiliary function for Fkn, which is relevant only
to wkn.
Proof. Since G(w,w) = Fkn(w) is obvious, we only need
to show that G(w,wtkn) ≥ Fkn(w). To do this, we compare
the Taylor series expansion of Fkn(w),







































Thus, (32) holds and G(w,wtkn) ≥ Fkn(w).
We can now demonstrate the convergence of
Theorem 1.
Figure 3 The boxplots of the clustering accuracies for NMF with diﬀerent loss functions over 100 runs on the six gene expression
datasets: (a) Leukemia, (b) Brain Tumor, (c) Lung Cancer, (d) 9 Tumors, (e) SRBCT, (f) DLBCL.
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Proof of Theorem 1. Replacing G(w,wt) in (27) by (30)
results in the update rule







Since (30) is an auxiliary function, Fkn is nonincreasing
under this update rule as in (25).
Similarly, we can also show that O is nonincreasing
under the updating steps in (24).
Experiments
Datasets
To test the proposed algorithm, we carry out exten-
sive experiments on six cancer-related gene expression
datasets. The six datasets consist of ﬁve multi-class
sets as used in [4,23] and one binary class set [24].
The descriptions of the six datasets are summarized in
Table 1. In these datasets, besides the gene expression
data samples, the labels are also given. They were obtained
from the diagnosis results and reported in diﬀerent
studies [23].
Performance metric
The proposed NMF-MCC algorithm will be used to rep-
resent gene expression data for k-means clustering. The
clustering results are evaluated by comparing the obtained
label of each sample with the label provided by the dataset.
The clustering accuracy is used to measure the cluster-
ing performance. Given a micro-array dataset containing
N samples that belong to K classes, we assume that K is
given in all the algorithms tested here. For each sample,
xn, let cn be the cluster label predicted by an algorithm and
rn be the cancer type label provided by the dataset. The





where I(A,B) returns 1 if A = B and 0 otherwise.
Testedmethods
We ﬁrst compared the MCC with other loss functions
between X and HW for the NMF algorithm on the
cancer clustering problem, including l2 norm distance,
KL distance [10], α-divergence [4], and earth mover’s
distance (EMC) [12]. We further compared the pro-
posed NMF-MCC algorithm with other NMF-based algo-
rithms, including the penalized matrix decomposition
Figure 4 The boxplots of the clustering accuracies for diﬀerent versions of NMF algorithms over 100 runs on the six gene expression
datasets: (a) Leukemia, (b) Brain Tumor, (c) Lung Cancer, (d) 9 Tumors, (e) SRBCT, (f) DLBCL.
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Figure 5 The gene weight vector learned by NMF-MCC with−ρ
on the SRBCT dataset.
(PMD) algorithm [7], the original NMF algorithm [22], the
sparse non-negative matrix factorization (SNMF) algo-
rithm [3], the non-smooth non-negative matrix factoriza-
tion (nsNMF) algorithm [9] and the projected gradient
kernel nonnegative matrix factorization (PGK-NMF).
Results
Since the initial H and W are selected randomly, we per-
formed 100 independent trials and computed the average
and the standard deviations of the accuracy for each loss
function. The results from the comparison of MCC with
other loss functions are presented in Figure 3. As shown
in Figure 3, MCC consistently performed the best on
all the six datasets. The other loss functions performed
well on some datasets, but poorly on the others. It seems
that the improvement of MCC increased when the num-
ber of genes increased. The standard deviation on the
accuracy of MCC was much smaller than the standard
deviation on the other loss functions, indicating thatMCC
is the most stable. On the other hand, EMD, although
worked quite well in computer vision tasks [12], it did
not perform well on gene expression data due to the sig-
niﬁcant diﬀerence between the image data and the gene
expression data.
The results of the comparison of NMF-MCC with
other related NMF methods are presented in Figure 4.
Figure 4 shows the performance of diﬀerent algorithms
on the six datasets. The NMF-MCC algorithm outper-
formed the other algorithms on ﬁve out of the six datasets.
The NMF-MCC algorithm could correctly cluster more
than 88% and 78% of the samples in the Leukemia and
DLBCL datasets, respectively, in a completely unsuper-
vised manner. In contrast, the l2 norm distance-based
NMF algorithm performed even worse than the baseline
PMD algorithm on the Leukemia and DLBCL datasets,
i.e., an average accuracy of 73% and 67%, respectively.
This veriﬁes that correntropy is a much better measure
of cancer clustering data. Note that NMF-MCC signif-
icantly outperformed the other algorithms on the Lung
Cancer dataset, which contains a large number of genes.
This implies that among the large number of genes,
only a small fraction is likely to be relevant to cancer-
ous tumor growth or spread. In NMF-MCC, the auxil-
iary variables −ρ acts as the feature selectors, we was
able to select the relevant genes. Although the SNMF
and nsNMF algorithms also improved on the perfor-
mance of the baseline NMF algorithm, the improvement
was much less than that of the NMF-MCC algorithm. A
possible reason is that many genes exhibit similar pat-
terns across all of the samples with only a few genes
diﬀerentiating diﬀerent cancer classes. They are likely
to be sampled from a nonlinear manifold. Hence, the
loss function deﬁned by a linear kernel with either the
Figure 6 Themeta-sample matrix,H, weighted by dig(−ρ) and the corresponding coding matrix,W , obtained from the NMF-MCC
algorithm for the SRBCT dataset.
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l2 norm or the KL distance could not capture them. In
contrast, the NMF-MCC algorithm had a loss function
that was deﬁned by the correntropy and a Gaussian ker-
nel, which could capture the nonlinear manifold structure
much more eﬀectively. By mapping the gene expression
data into the nonlinear dataspace by a Gaussian kernel,
the PGK-NMF outperformed the original NMF. How-
ever, our NMF-MCC could even further improve the
PGK-NMF by applying diﬀerent kernels to diﬀerent fea-
tures.
To understand what genes were selected by the NMF-
MCC algorithm, we drew the gene weight ﬁgure on the
SRBCT dataset (Figure 5). It can be seen that the −ρ
vector is sparse, which shows the signiﬁcance of cer-
tain genes. The resulting meta-sample matrix weighted
by −ρ with the corresponding coding matrix is shown
in Figure 6. By comparing to the coding matrix learned
by the original NMF with the l2 norm distance in
Figure 1, we determine that the coding matrix learned by
the NMF-MCC algorithm is much more discriminative
among diﬀerent cancer classes. On this dataset, the NMR-
MCC algorithm achieved an average clustering accuracy
of 63%.
Discussion
Traditional unsupervised learning techniques select fea-
tures with features selection algorithms and then do
clustering using the selected features. The NMF-MCC
algorithm proposed here achieves both goals simulta-
neously. The learned gene weight vector reﬂects the
importance of the genes in the gene clustering task, and
the coding matrix encodes the clustering results for the
samples.
Our experimental results demonstrate that the improve-
ment of NMR-MCC over the other methods increases
when the number of genes increases. This shows the
ability of the proposed algorithm to eﬀectively select
the important genes and cluster samples. This is an
important property because high-dimensional data anal-
ysis has become increasingly frequent and important in
diverse ﬁelds of sciences and engineering, and social sci-
ences, ranging from genomics and health sciences to
economics, ﬁnance and machine learning. For instance,
in genome-wide association studies, hundreds of thou-
sands of SNPs are potential covariates for phenotypes
such as cholesterol level or height. The large number
of features presents an intrinsic challenge to many clas-
sical problems, where usual low-dimensional methods
no longer apply. The NMF-MCC algorithm has been
demonstrated to work well on the datasets with small
numbers of samples but large numbers of features. It
can therefor provide a powerful tool to study high-
dimensional problems, such as genome-wide association
studies.
Conclusion
We have proposed a novel NMF-MCC algorithm for
gene expression data-based cancer clustering. Experi-
ments demonstrate that correntropy is a better measure
than the traditional l2 norm and KL distances for this task,
and the proposed algorithm signiﬁcantly outperforms the
existing methods.
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